These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 2217422

  • 1. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
    Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H.
    Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
    [No Abstract] [Full Text] [Related]

  • 2. Organ conservation in deeply invasive bladder cancer.
    Fair WR.
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract] [Full Text] [Related]

  • 3. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S.
    Scand J Urol Nephrol; 2002 Jun; 36(5):339-43. PubMed ID: 12487737
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F, Reese J, Torti FM.
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [Abstract] [Full Text] [Related]

  • 7. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 8. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW, Katz MH, Steinberg GD.
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract] [Full Text] [Related]

  • 9. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE.
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract] [Full Text] [Related]

  • 10. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E, Souhami L, Tanguay S, Rajan R.
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
    Stöckle M.
    Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
    [Abstract] [Full Text] [Related]

  • 15. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T, Tomic R, Ljungberg B.
    Scand J Urol Nephrol; 2009 Nov; 43(4):293-9. PubMed ID: 19363744
    [Abstract] [Full Text] [Related]

  • 16. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI, Tsolos C, Touloupidis S.
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [Abstract] [Full Text] [Related]

  • 17. Treatment of regionally advanced bladder cancer. An overview.
    Droller MJ.
    Urol Clin North Am; 1992 Nov; 19(4):685-93. PubMed ID: 1441025
    [Abstract] [Full Text] [Related]

  • 18. Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
    Tsai HK, Katz MS, Coen JJ, Zietman AL, Kaufman DS, Shipley WU.
    Urology; 2006 Dec; 68(6):1188-92. PubMed ID: 17141846
    [Abstract] [Full Text] [Related]

  • 19. The optimal management of T1G3 bladder cancer.
    Emiliozzi P, Pansadoro A, Pansadoro V.
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract] [Full Text] [Related]

  • 20. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI, Stadler WM, Bajorin DF.
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.